Therapeutic applications of compounds in the Magnolia family

Pharmacology and Therapeutics

Volumn 130, Issue 2, 2011, Pages 157-176

  Lee, Young Jung ^a   Lee, Yoot Mo ^a,b   Lee, Chong Kil ^a   Jung, Jae Kyung ^a   Han, Sang Bae ^a   Hong, Jin Tae ^a  

^a Chungbuk National University   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

4 O methylhonokiol; Alzheimer disease; Cancer; Cardiovascular disease; Honokiol; Inflammatory disease; Magnolia; Magnolol; Nerve; Obovatol

Indexed keywords

4 O METHYLHONOKIOL; ALPHA EUDESMOL; BETA EUDESMOL; CARYOLANEMAGNOLOL; CARYOPHYLLENE OXIDE; CLOVANEMAGNOLOL; COUMARIC ACID; DIHYDROHONOKIOL B; DIHYDROXYDIHYDROMAGNOLOL; EUDESHONOKIOLS A; EUDESHONOKIOLS B; EUDESMAGNOLOL; EUDESOBOVATOLS A; EUDESOBOVATOLS B; GAMMA EUDESMOL; GINGER EXTRACT; HONOKIOL; LIRIODENDRIN; MAGALDEHYDE B; MAGNOLIA EXTRACT; MAGNOLIA OFFICINALIS EXTRACT; MAGNOLIANIN; MAGNOLOL; MAGNOSALIN; OBOVATOL; SINAPIC ALDEHYDE; SYRINGARESINOL; SYRINGARESINOL 4' O BETA DEXTRO GLUCOPYRANOSIDE; SYRINGIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; ANXIETY DISORDER; ASTHMA; ATHEROSCLEROSIS; DEGENERATIVE DISEASE; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; GASTROINTESTINAL DISEASE; HUMAN; INFLAMMATORY DISEASE; LIVER DISEASE; NEUROTOXICITY; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW; STROKE; TRANQUILIZING ACTIVITY;

ANIMALS; CARDIOVASCULAR DISEASES; CHINA; HUMANS; INFLAMMATION; JAPAN; KOREA; MAGNOLIA; MEDICINE, EAST ASIAN TRADITIONAL; NEOPLASMS; NERVOUS SYSTEM DISEASES; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 79953654775     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.01.010     Document Type: Review

References (271)

1. Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S. K., Shishodia, S., & Aggarwal, B. B. (2006). Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69, 195-206. (Pubitemid 43048906)
2. Ahn, K. S., Sethi, G., Shishodia, S., Sung, B., Arbiser, J. L., & Aggarwal, B. B. (2006). Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res 4, 621-633. (Pubitemid 44497215)
3. Amblard, F., Govindarajan, B., Lefkove, B., Rapp, K. L., Detorio, M., Arbiser, J. L., et al. (2007). Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol. Bioorg Med Chem Lett 17, 4428-4431. (Pubitemid 47058969)
4. Appleton, K. M., Hayward, R. C., Gunnell, D., Peters, T. J., Rogers, P. J., Kessler, D., et al. (2006). Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr 84, 1308-1316.
5. Arab, L., & Liebeskind, D. S. (2010). Tea, flavonoids and stroke in man and mouse. Arch Biochem Biophys 501, 31-36.
6. Baghai, T. C., Volz, H. P., & Moller, H. J. (2009). Antidepressive pharmacotherapy. In slight and severe disease, young and old. Internist (Berl) 50, 235-243.
7. Baldwin, A. S. (2001). Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107, 241-246.
8. Bai, X., Cerimele, F., Ushio-Fukai, M., Waqas, M., Campbell, P. M., Govindarajan, B., et al. (2003). Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 278, 35501-35507.
9. Bailey, J. M., Muza, B., Hla, T., & Salata, K. (1985). Restoration of prostacyclin synthase in vascular smooth muscle cells after aspirin treatment: regulation by epidermal growth factor. J Lipid Res 26, 54-61. (Pubitemid 15133294)
10. Bang, K. H., Kim, Y. K., Min, B. S., Na, M. K., Rhee, Y. H., Lee, J. P., et al. (2000). Antifungal activity of magnolol and honokiol. Arch Pharm Res 23, 46-49.
11. Bastidas Ramirez, B. E., Navarro Ruiz, N., Quezada Arellano, J. D., Ruiz Madrigal, B., Villanueva Michel, M. T., & Garzon, P. (1998). Anticonvulsant effects of Magnolia grandiflora L. in the rat. J Ethnopharmacol 61, 143-152. (Pubitemid 28297904)
12. Battle, T. E., Arbiser, J., & Frank, D. A. (2005). The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106, 690-697. (Pubitemid 40981267)
13. Behl, C., & Moosmann, B. (2002). Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds. Biol Chem 383, 521-536. (Pubitemid 34506288)
14. Bian, Z. X., Zhang, G. S., Wong, K. L., Hu, X. G., Liu, L., Yang, Z., et al. (2006). Inhibitory effects of magnolol on distal colon of guinea pig in vitro. Biol Pharm Bull 29, 790-795.
15. Butterfield, D. A., & Lauderback, C. M. (2002). Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 32, 1050-1060. (Pubitemid 34603342)
16. Calabrese, V., Cornelius, C., Mancuso, C., Lentile, R., Stella, A. M., & Butterfield, D. A. (2009). Redox homeostasis and cellular stress response in aging and neurodegeneration. Methods Mol Biol 610, 285-308.
17. Calapai, G., Crupi, A., Firenzuoli, F., Marciano, M. C., Squadrito, F., Inferrera, G., Parisi, A., Rizzo, A., Crisafulli, C., Fiore, A., & Caputi, A. P. (2000). Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci 67, 2673-2683.
18. Cantley, L. C., & Neel, B. G. (1999). New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 96, 4240-4245. (Pubitemid 29190320)
19. Chang, C. Y., Lai, Y. C., Cheng, T. J., Lau, M. T., & Hu, M. L. (1998). Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan. Free Radical Res 28, 15-24.
20. Chang, C. P., Hsu, Y. C., & Lin, M. T. (2003). Magnolol protects against cerebral ischaemic injury of rat heatstroke. Clin Exp Pharmacol Physiol 30, 387-392. (Pubitemid 36713997)
21. Chao, W., & Olson, M. S. (1993). Platelet-activating factor: receptors and signal transduction. Biochem J 292(Pt 3), 617-629. (Pubitemid 23210185)
22. Chen, F., Wang, T., Wu, Y. F., Gu, Y., Xu, X. L., Zheng, S., et al. (2004). Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 10, 3459-3463. (Pubitemid 39549546)
23. Chen, Y. H., Lin, S. J., Chen, Y. L., Liu, P. L., & Chen, J. W. (2006). Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Hematol Disord Drug Targets 6, 279-304.
24. Chen, C. M., Liu, S. H., & Lin-Shiau, S. Y. (2007). Honokiol, a neuroprotectant against mouse cerebral ischaemia, mediated by preserving Na+, K+-ATPase activity and mitochondrial functions. Basic Clin Pharmacol Toxicol 101, 108-116.
25. Chen, L. C., Liu, Y. C., Liang, Y. C., Ho, Y. S., & Lee, W. S. (2009). Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21/Cip1. J Agric Food Chem 57, 7331-7337.
26. Chen, Y. H., Lin, F. Y., Liu, P. L., Huang, Y. T., Chiu, J. H., Chang, Y. C., et al. (2009). Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats. Arch Pharm Res 32, 221-228.
27. Chen, Z. A., Wang, J. L., Liu, R. T., Ren, J. P., Wen, L. Q., Chen, X. J., et al. (2009). Liquiritin potentiate neurite outgrowth induced by nerve growth factor in PC12 cells. Cytotechnology 60, 125-132.
28. Cherubini, A., Polidori, M. C., Bregnocchi, M., Pezzuto, S., Cecchetti, R., Ingegni, T., di Iorio, A., Senin, U., & Mecocci, P. (2000). Antioxidant profile and early outcome in stroke patients. Stroke 31, 2295-2300.
29. Choi, J. H., Ha, J., Park, J. H., Lee, J. Y., Lee, Y. S., Park, H. J., et al. (2002). Costunolide triggers apoptosis in human leukemia U937 cells by depleting intracellular thiols. Jpn J Cancer Res 93, 1327-1333. (Pubitemid 36104872)
30. Choi, J., Shin, K. M., Park, H. J., Jung, H. J., Kim, H. J., Lee, Y. S., et al. (2004). Anti-inflammatory and antinociceptive effects of sinapyl alcohol and its glucoside syringin. Planta Med 70, 1027-1032. (Pubitemid 39587035)
31. Choi, M. S., Lee, S. H., Cho, H. S., Kim, Y., Yun, Y. P., Jung, H. Y., et al. (2007). Inhibitory effect of obovatol on nitric oxide production and activation of NF-kappaB/MAP kinases in lipopolysaccharide-treated RAW 264.7cells. Eur J Pharmacol 556, 181-189. (Pubitemid 46098933)
32. Choi, N. H., Choi, G. J., Min, B. -S., Jang, K. S., Choi, Y. H., Kang, M. S., et al. (2009). Effects of neolignans from the stem bark of Magnolia obovata on plant pathogenic fungi. J Appl Microbiol 106, 2057-2063.
33. Collett, G. P., & Campbell, F. C. (2006). Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells. Carcinogenesis 27, 1285-1291. (Pubitemid 43985444)
34. Court, B. L.,& Nelson, G. E. (1996). In Taylor & Francis (Ed.), Bipolar Puzzle Solution (pp. 57)..
35. Cui, H. S., Huang, L. S., Sok, D. E., Shin, J., Kwon, B. M., Youn, U. J., et al. (2007). Protective action of honokiol, administered orally, against oxidative stress in brain of mice challenged with NMDA. Phytomedicine 14, 696-700. (Pubitemid 47419299)
36. Cuzzocrea, S. (2006). Role of nitric oxide and reactive oxygen species in arthritis. Curr Pharm Des 12, 3551-3570.
37. Deyama, T., Nishibe, S., & Nakazawa, Y. (2001). Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacol Sin 22, 1057-1070.
38. Dimmeler, S., Hermann, C., Galle, J., & Zeiher, A. M. (1999). Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol 19, 656-664. (Pubitemid 29135168)
39. Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22, 391-397. (Pubitemid 29453643)
40. Djuric, Z., Chen, G., Doerge, D. R., Heilbrun, L. K., & Kucuk, O. (2001). Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Lett 172, 1-6. (Pubitemid 32823466)
41. Drouet, B., Pincon-Raymond, M., Chambaz, J., & Pillot, T. (2000). Molecular basis of Alzheimer's disease. Cell Mol Life Sci 57, 705-715. (Pubitemid 30392029)
42. Eby, G. A., & Eby, K. L. (2006). Rapid recovery from major depression using magnesium treatment. Med Hypotheses 67, 362-370. (Pubitemid 43825609)
43. Eby, G. A., III, & Eby, K. L. (2010). Magnesium for treatment-resistant depression: a review and hypothesis. Med Hypotheses 74, 649-660.
44. el-Feraly, F. S., & Chan, Y. M. (1978). Isolation and characterization of the sesquiterpene lactones costunolide, parthenolide, costunolide diepoxide, santamarine, and reynosin from Magnolia grandiflora L. J Pharm Sci 67, 347-350.
45. Ellis, J. M. (2005). Cholinesterase inhibitors in the treatment of dementia. J Am Osteopath Assoc 105(3), 145-158.
46. Eriksson, A. C., Jonasson, L., Lindahl, T. L., Hedback, B., & Whiss, P. A. (2009). Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study. J Transl Med 7, 42.
47. Ernst, E. (2002). "Flower remedies": a systematic review of the clinical evidence. Wien Klin Wochenschr 114, 963-966.
48. Farlow, M., Gracon, S. I., Hershey, L. A., Lewis, K. W., Sadowsky, C. H., & Dolan-Ureno, J. (1992). A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. JAMA 268, 2523-2529.
49. Fischer, U., Janssen, K., & Schulze-Osthoff, K. (2007). Cutting-edge apoptosis-based therapeutics: a panacea for cancer? BioDrugs 21, 273-297.
50. Frank, B., & Gupta, S. (2005). A review of antioxidants and Alzheimer's disease. Ann Clin Psychiatry 17, 269-286. (Pubitemid 41780250)
51. Fukushima, M. (1997). Profiles of effects of traditional oriental herbal medicines on central nervous systems in humans - assessment of saiboku-to and saiko-karyukotsu- borei-to using EEG and pharmacokinetics of herbal medicine-derived ingredients as indices. Seishin Shinkeigaku Zasshi 99, 355-369.
52. Fukuyama, Y., Nakade, K., Minoshima, Y., Yokoyama, R., Zhai, H., & Mitsumoto, Y. (2002). Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons. Bioorg Med Chem Lett 12, 1163-1166. (Pubitemid 34270554)
53. Fuller, R. W. (1996). Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats. Behav Brain Res 73, 215-219.
54. Garg, A., & Aggarwal, B. B. (2002). Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 16, 1053-1068. (Pubitemid 34618844)
55. Gautam, A., Li, Z. R., & Bepler, G. (2003). RRM1-induced metastasis suppression through PTEN-regulated pathways. Oncogene 22, 2135-2142. (Pubitemid 36539563)
56. Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., et al. (1999). The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 60, 427-435. (Pubitemid 29369796)
57. Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.W., Egan, L. J., et al. (2004). IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285-296. (Pubitemid 39061110)
58. Griendling, K. K., & Ushio-Fukai, M. (1998). Redox control of vascular smooth muscle proliferation. J Lab Clin Med 132, 9-15. (Pubitemid 28329605)
59. Hahm, E. R., & Singh, S. V. (2007). Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol Cancer Ther 6, 2686-2695.
60. Hahm, E. R., Arlotti, J. A., Marynowski, S. W., & Singh, S. V. (2008). Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin Cancer Res 14, 1248-1257. (Pubitemid 351302574)
61. Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70. (Pubitemid 30046295)
62. Haraguchi, H., Ishikawa, H., Shirataki, N., & Fukuda, A. (1997). Antiperoxidative activity of neolignans from Magnolia obovata. J Pharm Pharmacol 49, 209-212. (Pubitemid 27096118)
63. Harrison, D. G. (1997). Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100, 2153-2157.
64. Hattori, M., Sakamoto, T., Endo, Y., Kakiuchi, N., Kobashi, K., Mizuno, T., et al. (1984). Metabolism of magnolol from magnoliae cortex. I. Application of liquid chromatography- mass spectrometry to the analysis of metabolites of magnolol in rats. Chem Pharm Bull (Tokyo) 32, 5010-5017.
65. Hattori, M., Endo, Y., Takebe, S., Kobashi, K., Fukasaku, N., & Namba, T. (1986). Metabolism of magnolol from Magnoliae cortex. II. Absorption, metabolism and excretion of [ring-14C]magnolol in rats. Chem Pharm Bull (Tokyo) 34, 158-167.
66. Healey, J. S., Hart, R. G., Pogue, J., Pfeffer, M. A., Hohnloser, S. H., De Caterina, R., et al. (2008). Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Stroke 39, 1482-1486.
67. Hennerici, M. G., Kay, R., Bogousslavsky, J., Lenzi, G. L., Verstraete, M., & Orgogozo, J. M. (2006). Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial. Lancet 368, 1871-1878. (Pubitemid 44794528)
68. Hibasami, H., Achiwa, Y., Katsuzaki, H., Imai, K., Yoshioka, K., Nakanishi, K., et al. (1998). Honokiol induces apoptosis in human lymphoid leukemia Molt 4B cells. Int J Mol Med 2, 671-673.
69. Hong, J. T., Ryu, S. R., Kim, H. J., Lee, J. K., Lee, S. H., Kim, D. B., et al. (2000). Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury. Brain Res Bull 53, 743-749. (Pubitemid 32120278)
70. Hong, J. T., Ryu, S. R., Kim, H. J., Lee, J. K., Lee, S. H., Yun, Y. P., et al. (2001). Protective effect of green tea extract on ischemia/reperfusion- induced brain injury in Mongolian gerbils. Brain Res 888, 11-18. (Pubitemid 32056258)
71. Hou, Y. C., Chao, P. D., & Chen, S. Y. (2000). Honokiol and magnolol increased hippocampal acetylcholine release in freely-moving rats. Am J Chin Med 28, 379-384.
72. Hou, W., Chen, L., Yang, G., Zhou, H., Jiang, Q., Zhong, Z., et al. (2008). Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models. Phytother Res 22, 1125-1132.
73. Hsu, H. -Y., & Hsu, C. -S. (1980). Commonly used Chinese herb formulas with illustrations. Los Angeles, California: Oriental Healing Arts Institute.
74. Hsu, Y. F., Lee, T. S., Lin, S. Y., Hsu, S. P., Juan, S. H., Hsu, Y. H., et al. (2007). Involvement of Ras/Raf-1/ERK actions in the magnolol-induced upregulation of p21 and cell-cycle arrest in colon cancer cells. Mol Carcinog 46, 275-283.
75. Hu, J., Chen, L. J., Liu, L., Chen, X., Chen, P. L., Yang, G., et al. (2008). Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity. Exp Mol Med 40, 617-628.
76. Huang, Y. H., Schafer-Elinder, L., Wu, R., Claesson, H. E., & Frostegard, J. (1999). Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin Exp Immunol 116, 326-331. (Pubitemid 29219732)
77. Huang, S. S., Tsai, M. C., Chih, C. L., Hung, L. M., & Tsai, S. K. (2001). Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci 69, 1057-1065. (Pubitemid 32701916)
78. Huang, S. H., Chen, Y., Tung, P. Y., Wu, J. C., Chen, K. H., Wu, J. M., et al. (2007). Mechanisms for the magnolol-induced cell death of CGTH W-2 thyroid carcinoma cells. J Cell Biochem 101, 1011-1022. (Pubitemid 47040881)
79. Ikeda, K., Sakai, Y., & Nagase, H. (2003). Inhibitory effect of magnolol on tumour metastasis in mice. Phytother Res 17, 933-937. (Pubitemid 37152762)
80. - of cultured rat hippocampal neurons via GABAc receptors. Neurosci Lett 312, 121-123.
81. Ishitsuka, K., Hideshima, T., Hamasaki, M., Raje, N., Kumar, S., Hideshima, H., et al. (2005). Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Blood 106, 1794-1800. (Pubitemid 41208596)
82. Ito, K., Iida, T., Ichino, K., Tsunezuka, M., Hattori, M., & Namba, T. (1982). Obovatol and obovatal, novel biphenyl ether lignans from the leaves of Magnolia obovata Thunb. Chem Pharm Bull (Tokyo) 30, 3347-3353.
83. Iwasaki, K., Wang, Q., Seki, H., Satoh, K., Takeda, A., Arai, H., et al. (2000). The effects of the traditional Chinese medicine, "Banxia Houpo Tang (Hange-Koboku To)" on the swallowing reflex in Parkinson's disease. Phytomedicine 7, 259-263.
84. Jackson, S. P., Nesbitt, W. S., & Kulkarni, S. (2003). Signaling events underlying thrombus formation. J Thromb Haemost 1, 1602-1612.
85. Jang, J. H., & Surh, Y. J. (2002). Beta-amyloid induces oxidative DNA damage and cell death through activation of c-Jun N terminal kinase. Ann NY Acad Sci 973, 228-236.
86. Jellinger, K. A. (2009). Recent advances in our understanding of neurodegeneration. J Neural Transm 116, 1111-1162.
87. Jenkins, D. J., Kendall, C. W., Vidgen, E., Vuksan, V., Jackson, C. J., Augustin, L. S., et al. (2000). Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein. Metabolism 49, 1496-1500.
88. Jiang, X., & Wang, X. (2004). Cytochrome C-mediated apoptosis. Annu Rev Biochem 73, 87-106. (Pubitemid 39050364)
89. Jneid, H., Bhatt, D. L., Corti, R., Badimon, J. J., Fuster, V., & Francis, G. S. (2003). Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. Arch Intern Med 163, 1145-1153. (Pubitemid 36613066)
90. Jordan, A. D., Kordik, C. P., Reitz, A. B., & Sanfillipo, P. J. (1996). Novel anxiolytic agents - 1994- to present. Expert Opin Ther Pat 6, 1047-1060. (Pubitemid 26335725)
91. Kalman, D. S., Feldman, S., Feldman, R., Schwartz, H. I., Krieger, D. R., & Garrison, R. (2008). Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial. Nutr J 7, 11.
92. Kang, K. A., Lee, K. H., Kim, S. Y., Kim, H. S., Kim, J. S., & Hyun, J. W. (2007). Cytoprotective effects of KIOM-79 on streptozotocin induced cell damage by inhibiting ERK and AP-1. Biol Pharm Bull 30, 852-858. (Pubitemid 46708625)
93. Kang, J. S., Lee, K. H., Han, M. H., Lee, H., Ahn, J. M., Han, S. B., et al. (2008). Antiinflammatory activity of methanol extract isolated from stem bark of Magnolia kobus. Phytother Res 22, 883-888.
94. Kassuya, C. A., Cremoneze, A., Barros, L. F., Simas, A. S., Lapa Fda, R., Mello-Silva, R., et al. (2009). Antipyretic and anti-inflammatory properties of the ethanolic extract, dichloromethane fraction and costunolide from Magnolia ovata (Magnoliaceae). J Ethnopharmacol 124, 369-376.
95. Kim, H. M., Bae, S. J., Kim, D.W., Kim, B. K., Lee, S. B., Lee, U. S., et al. (2007). Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells. Int Immunopharmacol 7, 1083-1091.
96. Kim, J. Y., Lim, H. J., Lee da, Y., Kim, J. S., Kim do, H., Lee, H. J., et al. (2009). In vitro anti-inflammatory activity of lignans isolated from Magnolia fargesii. Bioorg Med Chem Lett 19, 937-940.
97. Kim, Y. S., Lee, J. Y., Park, J., Hwang, W., Lee, J., & Park, D. (2010). Synthesis and microbiological evaluation of honokiol derivatives as new antimicrobial agents. Arch Pharm Res 33, 61-65.
98. Kimura, I., Kimura, M., Yoshizaki, M., Yanada, K., Kadota, S., & Kikuchi, T. (1983). Neuromuscular blocking action of alkaloids from a Japanese crude drug "Shin-l" (Flos Magnoliae) in frog skeletal muscle. Planta Med 48, 43-47.
99. Kimura, I., Chui, L. H., Fujitani, K., Kikuchi, T., & Kimura, M. (1989). Inotropic effects of (+/-)-higenamine and its chemically related components, (+)-R-coclaurine and (+)-S-reticuline, contained in the traditional sino-Japanese medicines "bushi" and "shin-i" in isolated guinea pig papillary muscle. Jpn J Pharmacol 50, 75-78.
100. Kimura, M., Kobayashi, S., Luo, B., & Kimura, I. (1990). Selective inhibition by magnosalin and magnoshinin, compounds from 'shin-i' (Flos magnoliae), of adjuvant-induced angiogenesis and granuloma formation in the mouse pouch. Int Arch Allergy Appl Immunol 93, 365-370.
101. Kimura, I., Nagaura, T., Kobayashi, S., & Kimura, M. (1992). Inhibitory effects of magnoshinin and magnosalin, compounds from "Shin-i" (Flos magnoliae), on the competence and progression phases in proliferation of subcultured rat aortic endothelial cells. Jpn J Pharmacol 60, 59-62.
102. Kimura, M., Kimura, I., Guo, X., Luo, B., & Kobayashi, S. (1992). Combined effects of Japanese-Sino medicine 'Kakkon-to-ka-senkyu-shin'i' and its related combinations and component drugs on adjuvant-induced inflammation in mice. Phytother Res 6, 209-216.
103. Kirkeboen, K. A., Andreassen, A. K., Kvernmo, H. D., & Strand, O. A. (1999). [Nitric oxide - basal biochemistry and physiological aspects]. TidsskrNor Laegeforen 119, 4056-4060.
104. Kita, T., Kume, N., Ishii, K., Horiuchi, H., Arai, H., & Yokode, M. (1999). Oxidized LDL and expression of monocyte adhesion molecules. Diab Res Clin Pract 45, 123-126. (Pubitemid 29457759)
105. Knapp, M. J., Knopman, D. S., Solomon, P. R., Pendlebury, W. W., Davis, C. S., & Gracon, S. I. (1994). A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. JAMA 271, 985-991. (Pubitemid 24099918)
106. Ko, C. H., Chen, H. H., Lin, Y. R., & Chan, M. H. (2003). Inhibition of smooth muscle contraction by magnolol and honokiol in porcine trachea. Planta Med 69, 532-536.
107. Kobayashi, S., Kimura, I., & Kimura, M. (1996). Inhibitory effect of magnosalin derived from Flos magnoliae on tube formation of rat vascular endothelial cells during the angiogenic process. Biol Pharm Bull 19, 1304-1306. (Pubitemid 26363624)
108. Kobayashi, S., Kobayashi, H., Matsuno, H., Kimura, I., & Kimura, M. (1998). Inhibitory effects of anti-rheumatic drugs containing magnosalin, a compound from 'Shin-i' (Flos magnoliae), on the proliferation of synovial cells in rheumatoid arthritis models. Immunopharmacology 39, 139-147.
109. Koetter, U., Barrett, M., Lacher, S., Abdelrahman, A., & Dolnick, D. (2009). Interactions of Magnolia and Ziziphus extracts with selected central nervous system receptors. J Ethnopharmacol 124, 421-425.
110. Kong, C. W., Tsai, K., Chin, J. H., Chan, W. L., & Hong, C. Y. (2000). Magnolol attenuates peroxidative damage and improves survival of rats with sepsis. Shock 13, 24-28.
111. Konoshima, T., Kozuka, M., Tokuda, H., Nishino, H., Iwashima, A., Haruna, M., et al. (1991). Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. J Nat Prod 54, 816-822.
112. Kroegel, C. (1988). The potential pathophysiological role of platelet-activating factor in human diseases. Klin Wochenschr 66, 373-378.
113. Kuo, D. H., Lai, Y. S., Lo, C. Y., Cheng, A. C., Wu, H., & Pan, M. H. (2010). Inhibitory effect of magnolol on TPA-induced skin inflammation and tumor promotion in mice. J Agric Food Chem 58, 5777-5783.
114. Kuribara, H., Stavinoha, W. B., & Maruyama, Y. (1998). Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. J Pharm Pharmacol 50, 819-826. (Pubitemid 28379279)
115. Kuribara, H., Kishi, E., Hattori, N., Okada, M., & Maruyama, Y. (2000). The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark. J Pharm Pharmacol 52, 1425-1429.
116. Kuribara, H., Kishi, E., Kimura, M., Weintraub, S. T., & Maruyama, Y. (2000). Comparative assessment of the anxiolytic-like activities of honokiol and derivatives. Pharmacol Biochem Behav 67, 597-601. (Pubitemid 32103571)
117. Kurkin, V. A., Dubishchev, A. V., Ezhkov, V. N., Titova, I. N., & Avdeeva, E. V. (2006). Antidepressant activity of some phytopharmaceuticals and phenylpropanoids. Pharm Chem J 401(11), 614-619. (Pubitemid 46639296)
118. Lahiri, D. K., Farlow, M. R., Grieg, N. H., & Sambamurti, K. (2002). Current drug targets for Alzheimer's disease treatment. Drug Dev Res 56, 267-281. (Pubitemid 35168304)
119. Lavrovsky, Y., Chatterjee, B., Clark, R. A., & Roy, A. K. (2000). Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 35, 521-532.
120. Ledgerwood, E. C., & Morison, I. M. (2009). Targeting the apoptosome for cancer therapy. Clin Cancer Res 15, 420-424.
121. Lee, B., Kim, C. H., & Moon, S. K. (2006). Honokiol causes the p21WAF1-mediated G(1)- phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells. FEBS Lett 580, 5177-5184. (Pubitemid 44437592)
122. Lee, S. K., Chun, H. K., Yang, J. Y., Han, D. C., Son, K. H., & Kwon, B. M. (2007). Inhibitory effect of obovatal on the migration and invasion of HT1080 cells via the inhibition of MMP-2. Bioorg Med Chem 15, 4085-4090. (Pubitemid 46695825)
123. Lee, S. J., Park, S. S., Lee, U. S., Kim, W. J., & Moon, S. K. (2008). Signaling pathway for TNF-alpha- induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells. Int Immunopharmacol 8, 1821-1826.
124. Lee, S. K., Kim, H. N., Kang, Y. R., Lee, C. W., Kim, H. M., Han, D. C., et al. (2008). Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis. Bioorg Med Chem 16, 8397-8402.
125. Lee, S. Y., Yuk, D. Y., Song, H. S., Yoon do, Y., Jung, J. K., Moon, D. C., et al. (2008). Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-kappaB. Eur J Pharmacol 582, 17-25.
126. Lee, D. H., Szczepanski, M. J., & Lee, Y. J. (2009). Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. J Cell Biochem 106, 1113-1122.
127. Lee, J. W., Lee, Y. K., Lee, B. J., Nam, S. Y., Lee, S. I., Kim, Y. H., et al. (2009). Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid. Pharmacol Biochem Behav 95, 31-40.
128. Lee, S. Y., Cho, J. S., Yuk, D. Y., Moon, D. C., Jung, J. K., Yoo, H. S., et al. (2009). Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB. J Pharmacol Sci 111, 124-136.
129. Lee, Y. K., Choi, I. S., Ban, J. O., Lee, H. J., Lee, U. S., Han, S. B., et al. (2010). 4-O-methylhonokiol attenuated beta-amyloid-induced memory impairment through reduction of oxidative damages via inactivation of p38 MAP kinase. [published online ahead of print August 5 2010] J Nutr Biochem. http://www.sciencedirect. com/science/article/B6T8P-50PJJ48-3/2/ feb8a62a17b536bb98515e38bca867ec. Accessed January 14, 2011.
130. Lee, Y. K., Choi, I. S., Kim, Y. H., Kim, K. H., Nam, S. Y., Yun, Y. W., et al. (2009). Neurite outgrowth effect of 4-O-methylhonokiol by induction of neurotrophic factors through ERK activation. Neurochem Res 34, 2251-2260.
131. Lee, Y. K., Yuk, D. Y., Kim, T. I., Kim, Y. H., Kim, K. T., Kim, K. H., et al. (2009). Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity. J Nat Med 63, 274-282.
132. Lehucher-Michel, M. P., Lesgards, J. F., Delubac, O., Stocker, P., Durand, P., & Prost, M. (2001). Oxidative stress and human disease. Current knowledge and perspectives for prevention. Presse Méd 30, 1076-1081.
133. Leonard, B. E. (1997). The role of noradrenaline in depression: a review. J Psychopharmacol 11, S39-S47.
134. Li, C. Y., Wang, Y., & Hu, M. K. (2003). Allylmagnolol, a novel magnolol derivative as potent antioxidant. Bioorg Med Chem 11, 3665-3671. (Pubitemid 36952265)
135. Li, H. B., Yi, X., Gao, J. M., Ying, X. X., Guan, H. Q., & Li, J. C. (2007). Magnolol-induced H460 cells death via autophagy but not apoptosis. Arch Pharm Res 30, 1566-1574.
136. Li, L., Han, W., Gu, Y., Qiu, S., Lu, Q., Jin, J., et al. (2007). Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore. Cancer Res 67, 4894-4903. (Pubitemid 46910198)
137. Li, N., Song, Y., Zhang, W., Wang, W., Chen, J., Wong, A. W., et al. (2007). Evaluation of the in vitro and in vivo genotoxicity of magnolia bark extract. Regul Toxicol Pharmacol 49, 154-159. (Pubitemid 350087392)
138. Lim, Y., Kwon, J. S., Kim, D. W., Lee, S. H., Park, R. K., Lee, J. J., et al. (2010). Obovatol from Magnolia obovata inhibits vascular smooth muscle cell proliferation and intimal hyperplasia by inducing p21Cip1. Atherosclerosis 210, 372-380.
139. Lin, S. Y., Chang, Y. T., Liu, J. D., Yu, C. H., Ho, Y. S., Lee, Y. H., et al. (2001). Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells. Mol Carcinog 32, 73-83.
140. Lin, S. Y., Liu, J. D., Chang, H. C., Yeh, S. D., Lin, C. H., & Lee, W. S. (2002). Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis. J Cell Biochem 84, 532-544.
141. Lin, Y. R., Chen, H. H., Ko, C. H., & Chan, M. H. (2005). Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures. Neuropharmacology 49, 542-550.
142. Lin, Y. R., Chen, H. H., Ko, C. H., & Chan, M. H. (2006). Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur J Pharmacol 537, 64-69.
143. Lin, Y. R., Chen, H. H., Ko, C. H., & Chan, M. H. (2007). Effects of honokiol and magnolol on acute and inflammatory pain models in mice. Life Sci 81, 1071-1078.
144. Lin, Y. R., Chen, H. H., Lin, Y. C., Ko, C. H., & Chan, M. H. (2009). Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain. J Biomed Sci 16, 94.
145. Liou, K. T., Shen, Y. C., Chen, C. F., Tsao, C. M., & Tsai, S. K. (2003). Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res 992, 159-166.
146. Liou, J. Y., Chen, Y. L., Loh, S. H., Chen, P. Y., Hong, C. Y., Chen, J. J., et al. (2009). Magnolol depresses urotensin-II-induced cell proliferation in rat cardiac fibroblasts. Clin Exp Pharmacol Physiol 36, 711-716.
147. Liu, B., Hattori, N., Zhang, N. Y., Wu, B., Yang, L., Kitagawa, K., et al. (2005). Anxiolytic agent, dihydrohonokiol-B, recovers amyloid beta protein-induced neurotoxicity in cultured rat hippocampal neurons. Neurosci Lett 384, 44-47. (Pubitemid 40826615)
148. Liu, Z., Zhang, X., Cui, W., Li, N., Chen, J., Wong, A. W., et al. (2007). Evaluation of short-term and subchronic toxicity of magnolia bark extract in rats. Regul Toxicol Pharmacol 49, 160-171. (Pubitemid 350087393)
149. Liu, H., Zang, C., Emde, A., Planas-Silva, M. D., Rosche, M., Kuhnl, A., et al. (2008). Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur J Pharmacol 591, 43-51.
150. Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., et al. (2010). Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121, e46-e215.
151. Loscher, W. (1998). Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog Neurobiol 54, 721-741.
152. Louajri, A., Harraga, S., Godot, V., Toubin, G., Kantelip, J. P., & Magnin, P. (2001). The effect of ginkgo biloba extract on free radical production in hypoxic rats. Biol Pharm Bull 24, 710-712. (Pubitemid 32586667)
153. Luo, L., Nong Wang, J., Kong, L. D., Jiang, Q. G., & Tan, R. X. (2000). Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula. J Ethnopharmacol 73, 277-281.
154. Luo, H., Zhong, Q., Chen, L. J., Qi, X. R., Fu, A. F., Yang, H. S., et al. (2008). Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer. J Cancer Res Clin Oncol 134, 937-945.
155. Ma, H., Jo, Y. J., Ma, Y., Hong, J. T., Kwon, B. M., & Oh, K. W. (2009). Obovatol isolated from Magnolia obovata enhances pentobarbital-induced sleeping time: possible involvement of GABAA receptors/chloride channel activation. Phytomedicine 16, 308-313.
156. Malinski, T. (2007). Nitric oxide and nitroxidative stress in Alzheimer's disease. J Alzheimers Dis 11, 207-218.
157. Maruyama, Y., Kuribara, H., Morita, M., Yuzurihara, M., & Weintraub, S. T. (1998). Identification of magnolol and honokiol as anxiolytic agents in extracts of saibokuto, an oriental herbal medicine. J Nat Prod 61, 135-138. (Pubitemid 28086994)
158. Matsuda, N., & Hattori, Y. (2006). Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy. J Pharmacol Sci 101, 189-198. (Pubitemid 44114312)
159. Matsuda, H., Kageura, T., Oda, M., Morikawa, T., Sakamoto, Y., & Yoshikawa, M. (2001). Effects of constituents from the bark of Magnolia obovata on nitric oxide production in lipopolysaccharide-activated macrophages. Chem Pharm Bull (Tokyo) 49, 716-720. (Pubitemid 32587118)
160. Matsui, N., Takahashi, K., Takeichi, M., Kuroshita, T., Noguchi, K., Yamazaki, K., et al. (2009). Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice. Brain Res 1305, 108-117.
161. Maynard, K. I., Ayoub, I. A., & Shen, C. C. (2001). Delayed multidose treatment with nicotinamide extends the degree and duration of neuroprotection by reducing infarction and improving behavioral scores up to two weeks following transient focal cerebral ischemia in Wistar rats. Ann NY Acad Sci 939, 416-424. (Pubitemid 32620095)
162. Millan, M. J. (1999). The induction of pain: an integrative review. Prog Neurobiol 57, 1-164.
163. Min, B. S. (2008). Anti-complement activity of phenolic compounds from the stem bark of Magnolia obovata. Nat Prod Sci 14, 196-201.
164. Mizutani, K., Ikeda, K., Nishikata, T., & Yamori, Y. (2000). Phytoestrogens attenuate oxidative DNA damage in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Hypertens 18, 1833-1840.
165. Mizutani, K., Ikeda, K., & Yamori, Y. (2000). Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Biochem Biophys Res Commun 274, 61-67. (Pubitemid 30496757)
166. Mokudai, T., Ayoub, I. A., Sakakibara, Y., Lee, E. J., Ogilvy, C. S., & Maynard, K. I. (2000). Delayed treatment with nicotinamide (vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats. Stroke 31, 1679-1685. (Pubitemid 30437523)
167. Moro, M. A., Almeida, A., Bolanos, J. P., & Lizasoain, I. (2005). Mitochondrial respiratory chain and free radical generation in stroke. Free Radic Biol Med 39, 1291-1304. (Pubitemid 41540085)
168. Mucci, M., Carraro, C., Mancino, P., Monti, M., Papadia, L. S., Volpini, G., et al. (2006). Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause. Minerva Ginecol 58, 323-334.
169. Muller, J. M., Ziegler-Heitbrock, H. W., & Baeuerle, P. A. (1993). Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187, 233-256. (Pubitemid 23150770)
170. Munroe, M. E., Arbiser, J. L., & Bishop, G. A. (2007). Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J Immunol 179, 753-763.
171. Nair, K. S., Rizza, R. A., O'Brien, P., Dhatariya, K., Short, K. R., Nehra, A., et al. (2006). DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 355, 1647-1659. (Pubitemid 44583955)
172. Nakazawa, T., Yasuda, T., & Ohsawa, K. (2003). Metabolites of orally administered Magnolia officinalis extract in rats and man and its antidepressant-like effects in mice. J Pharm Pharmacol 55, 1583-1591. (Pubitemid 37441366)
173. Namba, T., Nolte, C. T., Jackrel, J., & Grob, D. (1971). Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med 50, 475-492.
174. Nishida, K., Yasuda, E., Nagasawa, K., & Fujimoto, S. (2008). Altered levels of oxidation and phospholipase C isozyme expression in the brains of theanine-administered rats. Biol Pharm Bull 31, 857-860. (Pubitemid 351731976)
175. Nitti, M., Pronzato, M. A., Marinari, U. M., & Domenicotti, C. (2008). PKC signaling in oxidative hepatic damage. Mol Aspects Med 29, 36-42. (Pubitemid 351312217)
176. Niu, K., Hozawa, A., Kuriyama, S., Ebihara, S., Guo, H., Nakaya, N., et al. (2009). Green tea consumption is associated with depressive symptoms in the elderly. Am J Clin Nutr 90, 1615-1622.
177. Nomura, Y., & Okuma, Y. (1999). Age-related defects in lifespan and learning ability in SAMP8 mice. Neurobiol Aging 20, 111-115. (Pubitemid 29488721)
178. Nowak, G., Siwek, M., Dudek, D., Zieba, A., & Pilc, A. (2003). Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol 55, 1143-1147. (Pubitemid 38128954)
179. Nowak, G., Szewczyk, B., & Pilc, A. (2005). Zinc and depression. An update. Pharmacol Rep 57, 713-718.
180. Oh, J. H., Kang, L. L., Ban, J. O., Kim, Y. H., Kim, K. H., Han, S. B., et al. (2009). Anti-inflammatory effect of 4-O-methylhonokiol, a novel compound isolated from Magnolia officinalis through inhibition of NF-kappaB. Chem Biol Interact 180, 506-514.
181. Oikawa, T., Ito, G., Koyama, H., & Hanawa, T. (2005). Prokinetic effect of a Kampo medicine, Hange-koboku-to (Banxia-houpo-tang), on patients with functional dyspepsia. Phytomedicine 12, 730-734. (Pubitemid 41505329)
182. Oikawa, T., Ito, G., Hoshino, T., Koyama, H., & Hanawa, T. (2009). Hangekobokuto (Banxia-houpo-tang), a Kampo medicine that treats functional dyspepsia. Evid Based Complement Altern Med 6, 375-378.
183. Ou, H. C., Chou, F. P., Lin, T. M., Yang, C. H., & Sheu, W. H. (2006). Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells. Chem Biol Interact 161, 1-13.
184. Papakostas, G. I. (2005). Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder. Essent Psychopharmacol 6, 209-220.
185. Park, E. J., Zhao, Y. Z., Na, M., Bae, K., Kim, Y. H., Lee, B. H., et al. (2003). Protective effects of honokiol and magnolol on tertiary butyl hydroperoxide- or D-galactosamine-induced toxicity in rat primary hepatocytes. Planta Med 69, 33-37. (Pubitemid 36228454)
186. Park, E. J., Kim, S. Y., Zhao, Y. Z., & Sohn, D. H. (2006). Honokiol reduces oxidative stress, c-jun-NH2-terminal kinase phosphorylation and protects against glycochenodeoxycholic acid-induced apoptosis in primary cultured rat hepatocytes. Planta Med 72, 661-664.
187. Pietri, S., Seguin, J. R., d'Arbigny, P., Drieu, K., & Culcasi, M. (1997). Ginkgo biloba extract (Egb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery. Cardiovasc Drugs Ther 11, 121-131.
188. Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., et al. (2004). NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461-466. (Pubitemid 39329586)
189. Pyo, M. K., Lee, Y., & Yun-Choi, H. S. (2002). Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata. Arch Pharm Res 25, 325-328.
190. Qiang, L. Q., Wang, C. P., Wang, F. M., Pan, Y., Yi, L. T., Zhang, X., et al. (2009). Combined administration of the mixture of honokiol and magnolol and ginger oil evokes antidepressant-like synergism in rats. Arch Pharm Res 32, 1281-1292.
191. Raichle, M. E. (1983). The pathophysiology of brain ischemia. Ann Neurol 13, 2-10.
192. Ramaswamy, S., Nakamura, N., Vazquez, F., Batt, D. B., Perera, S., Roberts, T. M., et al. (1999). Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 96, 2110-2115. (Pubitemid 29117876)
193. Rex, A., Morgenstern, E., & Fink, H. (2002). Anxiolytic-like effects of Kava-Kava in the elevated plusmaze test - a comparisonwith diazepam. Prog Neuro-Psychopharmacol Biol Psychiatry 26, 855-860. (Pubitemid 35245552)
194. Rezai-Zadeh, K., Arendash, G. W., Hou, H., Fernandez, F., Jensen, M., Runfeldt, M., et al. (2008). Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res 1214, 177-187.
195. Ricciardolo, F. L., Sterk, P. J., Gaston, B., & Folkerts, G. (2004). Nitric oxide in health and disease of the respiratory system. Physiol Rev 84, 731-765. (Pubitemid 38823765)
196. Rice, D. P., & Miller, L. S. (1998). Health economics and cost implications of anxiety and other mental disorders in the United States. Br J Psychiatry 173, 4-9. (Pubitemid 28312191)
197. Rickels, K., & Schweizer, E. (1997). The clinical presentation of generalized anxiety in primary-care setting: practical concepts of classification and management. J Clin Psychiatry 58, 4-9.
198. Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., & Friedhoff, L. T. (1998). A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology 50, 136-145.
199. Sacco, R. L., Diener, H. C., Yusuf, S., Cotton, D., Ounpuu, S., Lawton, W. A., et al. (2008). Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 359, 1238-1251.
200. Sakakibara, Y., Mitha, A. P., Ogilvy, C. S., & Maynard, K. I. (2000). Post-treatment with nicotinamide (vitamin B(3)) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague-Dawley and Wistar rats. Neurosci Lett 281, 111-114. (Pubitemid 30125878)
201. Salvemini, D., Misko, T. P., Masferrer, J. L., Seibert, K., Currie, M. G., & Needleman, P. (1993). Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90, 7240-7244. (Pubitemid 23222425)
202. Sano, H., Hla, T., Maier, J. A., Crofford, L. J., Case, J. P., Maciag, T., et al. (1992). In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 89, 97-108.
203. Saver, J. L. (2006). Time is brain-quantified. Stroke 37, 263-266.
204. Schmidt, P. J., Daly, R. C., Bloch, M., Smith, M. J., Danaceau, M. A., St Clair, L. S., et al. (2005). Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 62, 154-162. (Pubitemid 40189131)
205. Scott, B. C., Butler, J., Halliwell, B., & Aruoma, O. I. (1993). Evaluation of the antioxidant actions of ferulic acid and catechins. Free Radical Res Commun 19, 241-253. (Pubitemid 23340481)
206. Seo, J. J., Lee, S. H., Lee, Y. S., Kwon, B. M., Ma, Y., Hwang, B. Y., et al. (2007). Anxiolytic-like effects of obovatol isolated from Magnolia obovata: involvement of GABA/benzodiazepine receptors complex. Prog Neuropsychopharmacol Biol Psychiatry 31, 1363-1369. (Pubitemid 47302547)
207. Sheu, M. L., Liu, S. H., & Lan, K. H. (2007). Honokiol induces calpain-mediated glucoseregulated protein-94 cleavage and apoptosis in human gastric cancer cells and reduces tumor growth. PLoS ONE 2, e1096.
208. Simmonds, R. E., & Foxwell, B.M. (2008). Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. Rheumatology (Oxford) 47, 584-590. (Pubitemid 351619194)
209. Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., et al. (2008). Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 133, 546S-592S.
210. Sirois, P., & Borgeat, P. (1984). [Leukotrienes]. Sem Hôp 60, 979-985.
211. Smith, M. T., Crouch, N. R., Gericke, N., & Hirst, M. (1996). Psychoactive constituents of the genus Sceletium N.E.Br. and other Mesembryanthemaceae: a review. J Ethnopharmacol 50, 119-130. (Pubitemid 26093790)
212. Squires, R. F., Ai, J., Witt, M. R., Kahnberg, P., Saederup, E., Sterner, O., et al. (1999). Honokiol and magnolol increase the number of [3H] muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of low-affinity sites. Neurochem Res 24, 1593-1602.
213. Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., et al. (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29-39. (Pubitemid 28458022)
214. Stone, M., Laughren, T., Jones, M. L., Levenson, M., Holland, P. C., Hughes, A., et al. (2009). Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 339, b2880.
215. Sugaya, A., Tsuda, T., Obuchi, T., & Sugaya, E. (1983). Effect of Chinese herbal medicine "Hange-Koboku-To" on laryngeal reflex of cats and in other pharmacological tests. Planta Med 47, 59-62.
216. Suh, S. J., Chung, T. W., Son, M. J., Kim, S. H., Moon, T. C., Son, K. H., et al. (2006). The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-kappaB regulation, in RAW264.7 cells. Arch Biochem Biophys 447, 136-146.
217. Sy, H. N., Wu, S. L., Wang, W. F., & Wang, S. J. (2008). Mechanisms underlying the honokiol inhibition of evoked glutamate release from glutamatergic nerve terminals of the rat cerebral cortex. Synapse 62, 890-901.
218. Syu, W. J., Shen, C. C., Lu, J. J., Lee, G. H., & Sun, C. M. (2004). Antimicrobial and cytotoxic activities of neolignans from Magnolia officinalis. Chem Biodivers 1, 530-537.
219. Tachikawa, E., Takahashi, M., & Kashimoto, T. (2000). Effects of extract and ingredients isolated from Magnolia obovata thunberg on catecholamine secretion from bovine adrenal chromaffin cells. Biochem Pharmacol 60, 433-440. (Pubitemid 30336641)
220. Tagami, M., Yamagata, K., Ikeda, K., Nara, Y., Fujino, H., Kubota, A., Numano, F., & Yamori, Y. (1998). Vitamin E prevents apoptosis in cortical neurons during hypoxia and oxygen reperfusion. Lab Invest 78, 1415-1429. (Pubitemid 28546085)
221. Takahashi, K., Kobayashi, H., Kobayashi, S., Kimura, I., Terasawa, K., & Kimura, M. (1996). Antiproliferative effects of magnosalin derived from 'Shin'i' (Flos Magnoliae), a Japanese Sino-medicine, on cultured synovial cells of MRL/1 and C57BL/6J mice. Phytother Res 10, 42-48.
222. Taniguchi, C., Homma, M., Takano, O., Hirano, T., Oka, K., Aoyagi, Y., et al. (2000). Pharmacological effects of urinary products obtained after treatment with saibokuto, a herbal medicine for bronchial asthma, on type IV allergic reaction. Planta Med 66, 607-611.
223. Taylor, M. J., Wilder, H., Bhagwagar, Z., & Geddes, J. (2004). Inositol for depressive disorders. Cochrane Database Syst Rev, CD004049.
224. Taylor, R. C., Cullen, S. P., & Martin, S. J. (2008). Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9, 231-241. (Pubitemid 351301823)
225. Teng, C. M., Chen, C. C., Ko, F. N., Lee, L. G., Huang, T. F., Chen, Y. P., et al. (1988). Two antiplatelet agents from Magnolia officinalis. Thromb Res 50, 757-765.
226. Teng, C. M., Yu, S. M., Chen, C. C., Huang, Y. L., & Huang, T. F. (1990). Inhibition of thrombin- and collagen-induced phosphoinositides breakdown in rabbit platelets by a PAF antagonist-denudatin B, an isomer of kadsurenone. Thromb Res 59, 121-130.
227. The Ridogrel Versus Aspirin Patency Trial (RAPT) investigators (1994). Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The ridogrel versus aspirin patency trial (RAPT). Circulation 89, 588-595.
228. Tsai, T. H., Chou, C. J., & Chen, C. F. (1994). Disposition of magnolol after intravenous bolus and infusion in rabbits. Drug Metab Dispos 22, 518-521.
229. Tsai, T. H., Chou, C. J., Cheng, F. C., & Chen, C. F. (1994). Pharmacokinetics of honokiol after intravenous administration in rats assessed using high-performance liquid chromatography. J Chromatogr B Biomed Appl 655, 41-45.
230. Tsai, T. H., Westly, J., Lee, T. F., Chen, C. F., & Wang, L. C. (1995). Effects of honokiol and magnolol on acetylcholine release from rat hippocampal slices. Planta Med 61, 477-479.
231. Tsai, T. H., Chou, C. J., & Chen, C. F. (1996). Pharmacokinetics and brain distribution of magnolol in the rat after intravenous bolus injection. J Pharm Pharmacol 48, 57-59. (Pubitemid 26128686)
232. Tse, A. K., Wan, C. K., Shen, X. L., Yang, M., & Fong, W. F. (2005). Honokiol inhibits TNF-alpha- stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Biochem Pharmacol 70, 1443-1457. (Pubitemid 41483455)
233. Tsuruga, T., Ebizuka, Y., Nakajima, J., Chun, Y. T., Noguchi, H., Iitaka, Y., et al. (1991). Biologically active constituents of Magnolia salicifolia: inhibitors of induced histamine release from rat mast cells. Chem Pharm Bull (Tokyo) 39, 3265-3271.
234. Ueda, H. (1999). In vivo molecular signal transduction of peripheral mechanisms of pain. Jpn J Pharmacol 79, 263-268.
235. Ueng, T. -H., Kang, J. -J., Wang, H. -W., & Lin, P. -C. (1997). An overview of the toxicology of commonly used traditional Chinese medicine. J Food Drug Anal 5, 241-264.
236. Ungvari, Z., Gupte, S. A., Recchia, F. A., Batkai, S., & Pacher, P. (2005). Role of oxidativenitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol 3, 221-229. (Pubitemid 40933045)
237. Varga-Szabo, D., Braun, A., & Nieswandt, B. (2009). Calcium signaling in platelets. J Thromb Haemost 7, 1057-1066.
238. Verro, P., Gorelick, P. B., & Nguyen, D. (2008). Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis. Stroke 39, 1358-1363. (Pubitemid 351440719)
239. Wang, J. P., Hsu, M. F., Raung, S. L., Chen, C. C., Kuo, J. S., & Teng, C. M. (1992). Antiinflammatory and analgesic effects of magnolol. Naunyn Schmiedebergs Arch Pharmacol 346, 707-712.
240. Wang, J. P., Ho, T. F., Chang, L. C., & Chen, C. C. (1995). Anti-inflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice. J Pharm Pharmacol 47, 857-860.
241. Wang, Y., Li, C. Y., Lin, I. H., Lee, A. R., & Hu, M. K. (2002). Synthesis and radical scavenging of novel magnolol derivatives. J Pharm Pharmacol 54, 1697-1703. (Pubitemid 36018821)
242. Wang, T., Chen, F., Chen, Z., Wu, Y. F., Xu, X. L., Zheng, S., et al. (2004). Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol 10, 2205-2208. (Pubitemid 39144968)
243. Wang, Y., Han, T., Zhu, Y., Zheng, C. J., Ming, Q. L., Rahman, K., et al. (2010). Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. J Nat Med 64, 24-30.
244. Watanabe, K., Watanabe, H., Goto, Y., Yamaguchi, M., Yamamoto, N., & Hagino, K. (1983). Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: central depressant effects. Planta Med 49, 103-108. (Pubitemid 14239052)
245. Weeks, B. S. (2009). Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian. Med Sci Monit 15, RA256-RA262.
246. Weiner, H. L., Lemere, C. A., Maron, R., Spooner, E. T., Grenfell, T. J., Mori, C., et al. (2000). Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann Neurol 48, 567-579.
247. Whittle, B. A. (1964). The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic alalgesics. Br J Pharmacol Chemother 22, 246-253.
248. Wittchen, H. U., & Hoyer, J. (2001). Generalized anxiety disorder: nature and course. J Clin Psychiatry 62, 15-21.
249. Wolkowitz, O. M., Reus, V. I., Keebler, A., Nelson, N., Friedland, M., Brizendine, L., et al. (1999). Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156, 646-649.
250. Wollemann, M. (1980). Receptors acting through adenylate cyclase in the CNS. Acta Physiol Acad Sci Hung 55, 299-304.
251. Xu, D., Lu, Q., & Hu, X. (2006). Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett 243, 274-280. (Pubitemid 44485849)
252. Xu, Q., Yi, L. T., Pan, Y., Wang, X., Li, Y. C., Li, J. M., et al. (2008). Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog Neuropsychopharmacol Biol Psychiatry 32, 715-725. (Pubitemid 351312371)
253. Yahara, S., Nishiyori, T., Kohda, A., Nohara, T., & Nishioka, I. (1991). Isolation and characterization of phenolic compounds from Magnoliae cortex produced in China. Chem Pharm Bull 39, 2024-2036.
254. Yamauchi, M., Hiraoka, S., & Imanishi, T. (2006). Role of the serotonergic nervous system in anxiety disorders and the anxiolytic mechanism of selective serotonin reuptake inhibitors. Nihon Shinkei Seishin Yakurigaku Zasshi 26, 193-198. (Pubitemid 46063758)
255. Yamamoto, Y., & Gaynor, R. B. (2001). Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 107, 135-142. (Pubitemid 32096826)
256. Yang, H. Y., & Chen, C. F. (1998). Pharmacology and toxicology of herbal medicine: subacute toxicity of commonly used Chinese drugs. J Toxicol Sci 23(Suppl 2), 229-233.
257. Yang, S. E., Hsieh, M. T., Tsai, T. H., & Hsu, S. L. (2002). Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochem Pharmacol 63, 1641-1651.
258. Yang, S. E., Hsieh, M. T., Tsai, T. H., & Hsu, S. L. (2003). Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells. Br J Pharmacol 138, 193-201.
259. Yang, Y. J., Park, J. I., Lee, H. J., Seo, S. M., Lee, O. K., Choi, D. H., et al. (2006). Effects of (+)-eudesmin from the stem bark of magnolia kobus DC. var. borealis Sarg. on neurite outgrowth in PC12 cells. Arch Pharm Res 29, 1114-1118.
260. Yao, S. K., Ober, J. C., Gonenne, A., Clubb, F. J., Jr., Krishnaswami, A., Ferguson, J. J., et al. (1993). Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries. Circ Res 73, 952-967. (Pubitemid 23306140)
261. Yatin, S. M., Aksenova, M., Aksenov, M., Markesbery, W. R., Aulick, T., & Butterfield, D. A. (1998). Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses. J Mol Neurosci 11, 183-197. (Pubitemid 29232849)
262. Yi, L. T., Xu, Q., Li, Y. C., Yang, L., & Kong, L. D. (2009). Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice. Prog Neuropsychopharmacol Biol Psychiatry 33, 616-624.
263. Yoshino, M., & Murakami, K. (1998). Interaction of iron with polyphenolic compounds: application to antioxidant characterization. Anal Biochem 257, 40-44. (Pubitemid 28117340)
264. Young, I. S., & Woodside, J. V. (2001). Antioxidants in health and disease. J Clin Pathol 54, 176-186. (Pubitemid 32205036)
265. Yu, J. Y., Lee, J. J., Jung, J. K., Kim, T. J., Yoo, H. S., Yun, Y. P., et al. (2009). JY0691, a newly synthesized obovatol derivative, inhibits cell cycle progression of rat aortic smooth muscle cells through up-regulation of p21(cip1). Eur J Pharmacol 624, 23-30.
266. Zhai, H., Nakade, K., Oda, M., Mitsumoto, Y., Akagi, M., Sakurai, J., et al. (2005). Honokiol-induced neurite outgrowth promotion depends on activation of extracellular signal-regulated kinases (ERK1/2). Eur J Pharmacol 516, 112-117. (Pubitemid 40799346)
267. Zhan, C., & Yang, J. (2006). Protective effects of isoliquiritigenin intransient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol Res 53, 303-309. (Pubitemid 43247544)
268. Zhang, W. W., Li, Y., Wang, X. Q., Tian, F., Cao, H., Wang, M. W., et al. (2005). Effects of magnolol and honokiol derived from traditional Chinese herbal remedies on gastrointestinal movement. World J Gastroenterol 11, 4414-4418. (Pubitemid 41093964)
269. Zhang, B., Maniatis, T., Song, Y., Zhang, W., Zhang, X., Li, N., et al. (2008). Evaluation of magnolia bark extract in chromosomal aberration assays. Mutat Res 654, 133-137.
270. Zheng, X., Wang, X., Gou, M., Zhang, J., Men, K., Chen, L., et al. (2010). A novel transdermal honokiol formulation based on Pluronic F127 copolymer. Drug Deliv 17, 138-144.
271. Zhou, H. Y., Shin, E. M., Guo, L. Y., Youn, U. J., Bae, K., Kang, S. S., et al. (2008). Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation. Eur J Pharmacol 586, 340-349.